Home › Epidermolysis Bullosa Dystrophica › California
Epidermolysis Bullosa Dystrophica clinical trials in California
7 studies for Epidermolysis Bullosa Dystrophica are looking for participants at sites in California.
Cities in California
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
- Lucile Packard Children's Hospital, Palo Alto
RecruitingObservational study
All ages · All sexes · Updated Sep 28, 2026 · NCT06423573A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
- Lucile Packard Children's Hospital, Palo Alto
RecruitingObservational study
All ages · All sexes · Updated Jul 14, 2026 · NCT07700966Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
- Stanford University, Redwood City
RecruitingPhase 1/2
Ages 6 and older · All sexes · Updated May 5, 2026 · NCT06834035Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
- Stanford University School of Medicine, Stanford
RecruitingObservational study
All ages · All sexes · Updated Apr 24, 2026 · NCT01019148A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
- Mission Dermatology Center, Rancho Santa Margarita
RecruitingPhase 3
6 Months · All sexes · Updated Mar 12, 2026 · NCT07016750MSC EVs in Dystrophic Epidermolysis Bullosa
- USC /Norris Comprehensive Cancer Center University of Southern California, Los Angeles
RecruitingPhase 1/2
6 Months · All sexes · Updated Jun 25, 2025 · NCT04173650Long-Term Follow-up Protocol
- Mission Dermatology Center, Rancho Santa Margarita
- Stanford University, Redwood City
RecruitingObservational study
6 Months · All sexes · Updated Jun 8, 2021 · NCT04917887From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.